Dr Simon Mitchell


  • BSc (1st Class Hons) Neuroscience — Parke Davis Prize in Neuroscience — University of Aberdeen
  • PhD in Biophysics and Pharmacology — University College London
  • PG Certificate (Distinction) in Intellectual Property — Bournemouth University
  • Postdocs at University College London, Cornell Medical College in New York, and MRC Laboratory of Molecular Biology in Cambridge, UK
  • Chartered Patent Attorney/European Patent Attorney
  • Professional Representative before EUIPO
  • UK Legal 500 recommended lawyer 2019

Simon advises a growing number of direct multinational clients and substantial foreign attorney firms in respect of patent application drafting, filing and prosecution, registered design filing and prosecution, contentious matters (e.g. oppositions, revocations) and advisory work.

His expertise focuses in the fields of human health, animal health and food security, and includes biotechnological, chemical and mechanical inventions. Specific areas of life sciences expertise include medicinal chemistry; biologics such as therapeutic peptides and proteins, including vaccines and antibodies; diagnostic methods; oligonucleotide therapeutics and probes for diagnosis and treatment, e.g. siRNA, miRNA; genetically-encoded reporter and cell-sorting systems; stem cells; microbiome-related inventions; medical devices; agriculture; and plant varieties.

Before joining the profession, Simon worked as postdoctoral researcher at University College London, the Biochemistry Department of Cornell Medical College in New York, and finally the Medical Research Council Laboratory of Molecular Biology in Cambridge, UK.

The focus of Simon’s academic research was the pharmacology, biophysics and biochemistry of synaptic transmission, which used electrophysiological, mechano-optical-photonic, genetic, biochemical and computational methods. His research was published in high-profile journals such as Nature, Nature Neuroscience, Neuron and the Journal of Neuroscience.

Simon is recommended in the Legal 500 2017, which states that he’s a key figure at UDL. Simon is singled out for “in-depth scientific knowledge, pragmatic advice and flexibility”, as part of a patent team that is praised for its “ability and willingness to dedicate resource when required to support urgent issues” and for its “extremely high” level of service.

Simon entered the profession in 2008 and joined UDL in 2015.


Our people

Articles by Dr Simon Mitchell



​Patentability of plants or animals — the Boards of Appeal of the EPO Boards of Appeal assert authority

A new EPO decision clarifies aspects of its position, but leaves many questions unanswered...

Read more



Microbiome inventions — patenting the gastric microbes that keep you healthy

Dr Simon Mitchell considers microbiome inventions at the European Patent Office.

Read more



CRISPR-Cas9 – from gene editing to EPO patent law editing?

Getting filing formalities correct is just as important as getting the science correct...

Read more

Website by Extreme